Search Grant Opportunities

Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed)

ID: RFA-AG-24-022 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

This funding opportunity announcement will support research focused on major toxicants observed to be associated with elevated AD risk, and health disparities in AD-related pathologic and clinical outcomes. This funding opportunity aims to enrich existing longitudinal cohorts with measures of exposures to individual toxicants or combinations of toxicants and/or multi-omics molecular profiling that reflects the bodys response to exposure(s), support the development of multi-disciplinary teams needed for the rigorous measurement and assessment of environmental exposures at the population level and create an environmental epidemiology consortium to facilitate rapid and broad data sharing, harmonization, and integration of complex exposure data across multiple studies to enhance the opportunity for data pooling and data integration for various meta-analyses and/or comparative analyses.
Background
The causes of AD/ADRD are multi-factorial in nature, and include factors related to aging, genetics, and the environment. Large scale multi-omic projects have greatly contributed to increasing knowledge of genomic variants and molecular/biological pathways involved in the development of AD/ADRD. However, the role of environmental exposures and their mechanisms that contribute to the pathogenesis of sporadic AD/ADRD remains an area of research that requires further exploration.

The evaluation of environmental exposures has been limited due, in part, to the variation of the methods of measuring environmental exposures, the number of exposures, the multiple sources of exposures, and rarity of certain exposures. Importantly, exposures earlier in life are likely to take decades to impact risk of developing AD/ADRD, and this adds a level of complexity to exposure research.

Classes of toxicants and chemicals that are persistent in the environment and accumulate in humans, such as toxic metals, per- and polyfluorinated alkyl substances (PFAS), industrial chemical mixtures, and contaminants from other sources, represent novel or understudied human exposures where research regarding their potential to increase the risk for AD/ADRD is needed. With evidence that environmental factors are contributors to AD/ADRD, well-designed epidemiology studies will play a key role in the evaluation of health effects from environmental toxicants and will be highly informative in drawing conclusions regarding these risks to human health.

In addition, the impact of the chemical/toxicant exposure on disparities of AD/ADRD is not well understood. Consequently, the paucity of a robust epidemiologic literature translates to a substantial need for studies that could help clarify the etiologic role of environmental toxicants on AD/ADRD development. Further, understanding exposures within real-world environmental settings and the subsequent health effects will require close collaboration across different scientific fields, particularly toxicology, epidemiology, exposure science, risk assessment and statistics, and proper integration of data from each of these disciplines.

Grant Details
This funding opportunity aims to enrich existing longitudinal cohorts with measures of exposures to individual toxicants or combinations of toxicants; support the development of multi-disciplinary teams needed for rigorous measurement and assessment of environmental exposures at the population level; create an environmental epidemiology consortium to facilitate rapid and broad data sharing; harmonization; integration of complex exposure data across multiple studies; enhance data pooling; data integration for various meta-analyses; comparative analyses; promote collaborative research to support addition of environmental exposure measures to well-phenotyped longitudinal AD/ADRD cohorts; addition of AD outcome/biomarker measurements to non-AD/ADRD cohorts with individuals spanning early mid-life (age 30-50) enriched with exposure measurements and measurements of AD biomarkers; investigate differences in response to toxicants by sex if possible.

Eligibility Requirements
Eligible applicants include higher education institutions; public/state controlled institutions; private institutions; nonprofits with 501(c)(3) IRS status (other than institutions); for-profit organizations (including small businesses); local governments; state governments; county governments; city or township governments; special district governments; Indian/Native American tribal governments (federally recognized); Indian/Native American tribal governments (other than federally recognized); federal government agencies; U.S. territory or possession agencies; independent school districts; public housing authorities/Indian housing authorities; Native American tribal organizations (other than federally recognized tribal governments); faith-based or community-based organizations; regional organizations; non-domestic (non-U.S.) entities (foreign institutions).

Period of Performance
The period of performance is over 5 years with an earliest start date in October 2023.

Grant Value
NIA intends to commit $11 million in fiscal year 2024 to support 4-5 awards. Application budgets are limited to $1.5 million in direct costs per year over 5 years.

Overview

Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 5/15/23 the National Institutes of Health posted grant opportunity RFA-AG-24-022 for Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed). The grant will be issued under grant program 93.866 Aging Research.

Timing

Posted Date
May 15, 2023, 12:00 a.m. EDT
Closing Date
Oct. 23, 2023, 12:00 a.m. EDT Past Due
Last Updated
May 16, 2023, 12:49 p.m. EDT
Version
1
Archive Date
Nov. 28, 2023

Eligibility

Eligible Applicants
Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Public housing authorities/Indian housing authorities
Private institutions of higher education
State governments
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Public and State controlled institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Native American tribal governments (Federally recognized)
Independent school districts
For profit organizations other than small businesses
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$1,500,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-022.html

Documents

Posted documents for RFA-AG-24-022

Grant Awards

Grants awarded through RFA-AG-24-022

Incumbent or Similar Grants

Grants similar to RFA-AG-24-022

Similar Active Opportunities

Open grant opportunities similar to RFA-AG-24-022